The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 112.00
Bid: 112.00
Ask: 113.00
Change: 0.50 (0.45%)
Spread: 1.00 (0.893%)
Open: 109.50
High: 112.00
Low: 109.50
Prev. Close: 111.50
LIT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Global cooperation agreement with law firm

25 Mar 2019 07:00

RNS Number : 8044T
Litigation Capital Management Ltd
25 March 2019
 

25 March 2019

Litigation Capital Management Limited

("LCM" or the "Company")

 

Global cooperation agreement with leading international law firm

 

Litigation Capital Management Limited (AIM:LIT) (LCM), a leading international provider of litigation financing solutions, announces that it has entered into a global cooperation agreement with a leading international law firm.

 

The global cooperation agreement puts LCM in prime position to finance disputes undertaken by the law firm and its clients. LCM has agreed to make available access to significant funding for disputes as they arise for the law firm and its clients, regardless of geography or jurisdiction; that meet the Company's rigorous due diligence process.

 

The law firm, which is headquartered in London, operates across six continents through a network of 50 offices and over 400 partners. The law firm is one of the most active in the litigation space globally and works with clients across sectors including aviation, energy and natural resources, infrastructure, trade and commodities, and insurance.

 

Patrick Moloney, Chief Executive Officer of LCM, said:

"We're delighted to have agreed this global cooperation agreement with one of the leading law firms worldwide and one of the most active in the litigation space. The partners at the firm will have access to funding that LCM is providing, regardless of jurisdiction or geography.

 

"Our on-the-ground presence through offices in London, Sydney and Singapore allows us to support the law firm and its clients. This agreement will increase the number of potential funding opportunities available to LCM, in addition to our already substantial pipeline of investment opportunities, which we continually evaluate in line with our rigorous due-diligence procedures."

 

CONTACTS

 

Litigation Capital Management

Patrick Moloney, Chief Executive Officer

Nick Rowles-Davies, Executive Director

 

Hawthorn Advisors lcm@hawthornadvisors.com

Lorna Cobbett / Zinka MacHale Tel: 020 3745 4960

 

NOTES TO EDITORS

 

About LCM

Litigation Capital Management ("LCM") is a leading international provider of litigation financing solutions. This includes single-case and portfolios across class actions, commercial claims, claims arising out of insolvency and international arbitration. LCM has an unparalleled track record, driven by effective project selection, active project management and robust risk management. Headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM has been listed on AIM since December 2018, trading under the ticker LIT. www.lcmfinance.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRLLFIDVIISFIA
Date   Source Headline
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
8th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
23rd Nov 20234:51 pmRNSDirector/PDMR Shareholding
31st Oct 20233:53 pmRNSExercise of Awards
17th Oct 20231:00 pmRNSResult of AGM
10th Oct 20237:00 amRNSTransaction in Own Shares
9th Oct 20237:00 amRNSTransaction in Own Shares
5th Oct 20231:40 pmRNSDirector/PDMR Shareholding
5th Oct 20237:00 amRNSShare Buyback Programme
2nd Oct 20237:00 amRNSDividend currency entitlement
19th Sep 20237:00 amRNSFinal Results
13th Sep 20231:00 pmRNSLondon Investor Event
12th Sep 20234:17 pmRNSNotice of AGM - Correction
12th Sep 20237:00 amRNSNotice of AGM
4th Sep 20237:00 amRNSSettlement in Australian class action
30th Aug 20237:00 amRNSNotice of Results
27th Jul 20237:00 amRNSUpdate following Supreme Court ruling
20th Jul 20237:00 amRNSProgress on Fund I investment
18th Jul 20237:00 amRNSFair Value Accounting and Dividend Payment
22nd Jun 20237:00 amRNSSuccessful resolution of balance sheet investment
19th Jun 20237:00 amRNSResolution of Investment
15th May 20239:48 amRNSSettlement in Australian class action
3rd Apr 20237:00 amRNSResolution of investment
20th Mar 20237:00 amRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSHalf-year Report
9th Mar 20237:00 amRNSSettlement in Australian class action
27th Feb 20239:30 amRNSNotice of Results
23rd Feb 20237:00 amRNSProgress on direct balance sheet investment
20th Feb 20237:00 amRNSSuccessful settlement in the Carillion claim
20th Dec 20227:00 amRNSProgress on portfolio of Investments
29th Nov 20227:00 amRNSDirector/PDMR Shareholding
16th Nov 20227:04 amRNSResult of AGM
20th Oct 20227:00 amRNSNew Litigation Finance Agreement
19th Oct 20229:26 amRNSNotice of AGM
13th Oct 20223:44 pmRNSIncentive Awards
4th Oct 20227:00 amRNSSecond close of Global Alternative Returns Fund II
29th Sep 20229:30 amRNSDirector/PDMR Shareholding
26th Sep 20226:00 pmRNSDirector/PDMR Shareholding
20th Sep 20227:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.